Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Infectious Diseases

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Favipiravir vs no treatment, supportive treatment, or other antiviral treatment

Serious adverse events attributable to the drug · people with confirmed COVID‐19

Favipiravir showed no clear difference in serious adverse events attributable to the drug compared with no treatment, supportive treatment, or other antiviral treatment (low certainty).

1 finding from 1 review

Favipiravir for treating COVID‐19 2024 · Cochrane Headline outcomes only
RR 1.04 [0.76, 1.42]
12 studies · 3317 participants
Low